4.9(top 10%)
Impact Factor
5.3(top 10%)
extended IF
182(top 1%)
H-Index
4.2K
authors
15.2K
papers
478.8K
citations
8K
citing journals
81.5K
citing authors

Most Cited Articles of Gynecologic Oncology

TitleYearCitations
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer20081.9K
Two pathogenetic types of endometrial carcinoma19831.6K
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study20041.3K
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study19911.1K
A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study1999861
Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study1990730
Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging2008601
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass2009557
The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform2009536
The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study2000530
Uterine sarcomas: a review2010518
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass2008506
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?2006466
Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling1995453
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study1992440
Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model1992419
Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study1998417
Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor model1995415
The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy1989413
Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice1992406
Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-19992004400
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm2009399
Uterine papillary serous carcinoma: patterns of metastatic spread1994389
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis2012383
Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva1990353